S 1387 United States Senate · 119th Congress

National Biotechnology Initiative Act of 2025

The National Biotechnology Initiative Act of 2025 establishes a coordinated Federal effort to advance biotechnology for national security, economic competitiveness, and innovation. It creates a National Biotechnology Coordination Office within the Executive Office of the President, led by a Director appointed by the President, to oversee coordination across 14 participating federal departments and agencies including Agriculture, Defense, Health and Human Services, and Energy. The bill requires the development of a national biotechnology strategy, regulatory streamlining for biotechnology products, workforce development programs, and improved public understanding of biotechnology (bioliteracy). It authorizes $22 million for fiscal year 2026, increasing to $35 million for 2027, with annual reports to Congress and a comprehensive national strategy required every five years. The Initiative will wind down after 20 years, transitioning to serve as an executive secretariat for ongoing biotechnology coordination.
Bill status in committee 1 of 4 stages cleared
Introduction
Apr 2025
Committee Review
Floor Vote
President
Introduced Apr 9, 2025 Last action Mar 19, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
1
Committee
2
Mar 19, 2026
Upper · Passed
Committee on Health, Education, Labor, and Pensions. Hearings held.
upper
Apr 9, 2025
Committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
upper
Apr 9, 2025
Introduced
Introduced in Senate
upper
1 primary · 1 co-sponsor

Sponsors